News & Publications

Press Releases

Dec 20, 2018

Jnana Therapeutics Expands Board of Directors and Forms Scientific Advisory Board

Stuart Schreiber, Ph.D. and Brian Cali, Ph.D. appointed to Board Inaugural SAB comprises renowned leaders in the investigation of disease biology and applications to drug discovery and development Boston,…

Read More >

Nov 6, 2018

Jnana Therapeutics Announces Appointment Of Joanne Kotz, Ph.D. As Chief Executive Officer

Boston Mass. – Nov. 6, 2018 – Jnana Therapeutics today announced that Joanne Kotz, Ph.D., a company co-founder, has been named Chief Executive Officer. Dr. Kotz has served as…

Read More >

Oct 9, 2018

Neurocrine Biosciences And Jnana Therapeutics Enter Strategic Collaboration To Discover Novel Medicines To Treat Central Nervous System Disorders

Partnership Leverages Neurocrine’s Expertise in Neuroscience and Jnana’s Proprietary Drug Discovery Platform Targeting the Solute Carrier Family of Transporters SAN DIEGO and BOSTON, Oct. 9, 2018 – Neurocrine Biosciences,…

Read More >

Oct 2, 2018

FierceBiotech Names Jnana Therapeutics As One Of Its “Fierce 15” Biotech Companies Of 2018

Boston, Mass. – October 2, 2018 – Jnana Therapeutics today announced that it has been named by FierceBiotech as one of 2018’s Fierce 15 biotechnology companies, designating it as…

Read More >

Dec 14, 2017

Jnana Therapeutics Launches With $50 Million Series A Financing To Target The Cell’s Metabolic Gates

Top-tier syndicate backs serial entrepreneur and world-renowned academics Stuart Schreiber and Ramnik Xavier Boston, Mass., December 14, 2017 – Jnana Therapeutics Inc. today announced a $50 million Series A…

Read More >


Oct 14, 2018

Jnana Therapeutics tries to take on an untapped class of proteins

Chemical and Engineering News, October 2018